Balyasny Asset Management
ASBP

Balyasny Asset Management’s Aspire Biopharma Holdings, Inc. Common Stock ASBP Stock Holding History

Balyasny Asset Management’s Portfolio ASBP Stock Details ASBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-402,181
Closed -$4.21M – 2398
2023
Q1 		$4.21M Hold
402,181
– – 0.01% 860
2022
Q4 		$4.15M Hold
402,181
– – 0.01% 822
2022
Q3 		$4.08M Hold
402,181
– – 0.01% 843
2022
Q2 		$4.01M Buy
+402,181
New +$4.01M 0.01% 830